New kidney drug shows promise in early safety trial
NCT ID NCT01279538
First seen Nov 17, 2025 · Last updated May 23, 2026 · Updated 23 times
Summary
This study tested a new medicine called ASKP1240 in 50 people who just received a kidney transplant. The goal was to see how the drug moves through the body and if it is safe. Participants received a single dose of the drug or a placebo. The study is complete and helps researchers understand the drug's effects for future use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor University Medical Center
Dallas, Texas, 75246, United States
-
Beth Israel Deaconess Medical Center, The Transplant Institute
Boston, Massachusetts, 02215, United States
-
California Institute of Renal Research
San Diego, California, 92123, United States
-
California Pacific Medical Center
San Francisco, California, 94115, United States
-
Central Pennsylvania Transplant Associates
Harrisburg, Pennsylvania, 17104, United States
-
Christ Hospital
Cincinnati, Ohio, 45219, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Emory University
Atlanta, Georgia, 30322, United States
-
Loyola University Medical Center
Maywood, Illinois, 60153, United States
-
Methodist University Hospital
Memphis, Tennessee, 38104, United States
-
St. Barnabas Medical Center
Livingston, New Jersey, 07039, United States
-
Stanford University Medical Center
Palo Alto, California, 94304, United States
-
The Methodist Hospital
Houston, Texas, 77030, United States
-
UCSF Medical Center
San Francisco, California, 94143, United States
-
University of Cincinnati - University Internal Medicine Associates
Cincinnati, Ohio, 45219, United States
-
University of Colorado Denver
Aurora, Colorado, 80045, United States
-
University of Illinois Medical Center
Chicago, Illinois, 60612, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
-
University of Utah Hospital
Salt Lake City, Utah, 84132, United States
-
University of Wisconsin
Madison, Wisconsin, 53705, United States
Conditions
Explore the condition pages connected to this study.